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Opsonic deficiency of the peritoneal cavity: A risk factor for peritonitis
in continuous ambulatory peritoneal dialysis. Staphylococcus epidermi-
dis peritonitis frequently complicates the clinical course of patients
treated with continuous ambulatory peritoneal dialysis (CAPD). Since
bacterial opsonization is critical to the effective defense of the peritone-
al cavity by phagocytic cells, we prospectively evaluated the opsonic
activity of peritoneal dialysis effluent obtained from 17 CAPD patients
during 102 patient months. Samples of pentoneal dialysis effluent
contained concentrations of opsonins against S. epidermidis that were
less than 2% of that observed in serum. Moreoever, heat-labile opsonic
activity against Escherichia coli was absent from all dialysis effluents.
During the study, there were ten episodes of peritonitis in nine CAPD
patients (1 per 10.2 patient months). S. epidermidis was isolated in
seven episodes, a gram-negative bacillus in one, and two episodes were
culture negative. The incidence of S. epidermidis peritonitis was I per
62 patient months in the patients with "high" peritoneal dialysis
effluent opsonic activity against S. epidermidis but was nearly tenfold
greater in patients with "low" opsonic activity (1 per 6.7 patient
months). We conclude that peritoneal dialysis effluent opsonic activity
predicts which CAPD patients are at an increased risk to develop S.
epidermidis peritonitis.
Deficit d'opsonisation dans l'effluent de dialyse péritonéale: Un facteur
de risque de péritonite lors de Ia dialyse péritonéale continue ambulatoire.
Une péritonite par Staphylococcus epidermidis complique fréquem-
ment l'évolution clinique de malades traités par dialyse pdritonéale
continue ambulatoire (CAPD). Puisque l'opsonisation bactérienne est
critique pour Ia defense effective de Ia cavitC pCritonéale par les cellules
phagocytaires, nous avons évalué prospectivement l'activité d'opsoni-
sation de l'effluent de dialyse péritonéale provenant de 17 malades en
CAPD pendant 102 mois-malades. Des échantillons d'effluent de dia-
lyse péritonéale contenaient des concentrations d'opsonine contre S.
epidermidis qui étaient de moms de 2% de celles observées dans le
serum. De plus, l'activitC opsonisante détruite par Ia chaleur contre
Escherichia coli dtait absente de tous les effluents de dialyse. Pendant
l'ëtude, ii y a eu dix episodes de péritonite chex neuf malades en CAPD
(1 pour 10,2 mois-malades). S. epidermidis a Cté isolé dans sept
episodes un bacille gram-négatif dans un, et dans deux episodes, Ia
culture était negative. L'incidence de Ia péritonite a s. epidermidis était
de 1 pour 62 mois-malades chez les malades avec un effluent de dialyse
contenant une activité opsonisante "elevée" contre S. epidermidis mais
Ctait presque dixfois supérieure chez les malades avec une "faible"
activitC opsonisante (I pour 6,7 mois-malades). Nous concluons que
l'activité opsonisante de l'effluent de dialyse péritonéale prédit quels
malades en CAPD ont un risque accru de développer une pCritonite a S.
epidermidis.
Peritonitis is a frequent complication of continuous ambula-
tory peritoneal dialysis (CAPD) and is a major factor that limits
the widespread application of this therapy [1]. Gram-positive
organisms, particularly coagulase-negative staphylococci (gen-
erally referred to as Staphylococcus epidermidis), are frequent-
539
ly isolated from CAPD patients who have peritonitis. Although
improvement in techniques have helped to reduce this compli-
cation, the majority of CAPD patients will develop peritonitis at
some point in their clinical course [2—6].
Host defense mechanisms of the peritoneal cavity during
CAPD evaluated by our laboratory demonstrate that the phago-
cytic and bactericidal capacity of peritoneal macrophages
(PMØ) from uninfected peritoneal dialysis patients is similar to
that of normal circulating polymorphonuclear leukocytes
(PMN) [7, 81. However, efficient microbicidal function of
phagocytic cells generally requires that bacterial species be
opsonized with molecules that facilitate ingestion of these
microorganisms 19—11]. Opsonic molecules have been charac-
terized as either heat-stable or heat-labile and represent
immunoglobulin and complement components, respectively [9-
11]. Our previous data suggest that in contrast to normal serum,
peritoneal dialysis effluents (PDE) obtained from daily ex-
changes of CAPD patients contained low titers of heat-stable
and virtually no heat-labile opsonic activity [7, 8].
Since bacterial opsonization is a critical step in the ingestion
and microbicidal functions of phagocytic cells, an opsonic
deficiency could be an important underlining factor in the
pathogenesis of peritonitis in CAPD patients. The present
studies were designed to evaluate the role of such an opsonic
deficiency in the development of peritonitis in these patients.
Methods
Patient population. From December 1981 until November
1982, 17 CAPD patients treated at the Regional Kidney Disease
Program, Hennepin County Medical Center, Minneapolis, Min-
nesota were prospectively studied. Twelve patients received
CAPD as their initial and only therapy for renal failure. Four of
these CAPD patients had received this therapy for 6 to 18
months (8.7 3.2 months) before entry into the study. The
remaining five patients were treated with hemodialysis for 6 to
24 months before initiation of CAPD. All patients were treated
with a standard 2-liter exchange four times per day. Dialysis
solutions containing 1.5 or 2.5% dextrose concentrations (Dian-
eal, Baxter-Travenol Laboratories, Deerfield, Illinois) were
used for each exchange. Samples of the PDE were obtained at
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the completion of an overnight exchange during the first 2
weeks after the initiation of CAPD and thereafter at 2 to 3
monthly intervals. Usually 2.5% Dianeal is utilized during an
overnight exchange. Samples of PDE from only uninfected
patients were obtained at the end of an overnight exchange and
centrifuged; a cell free 50-mi sample was stored at —70°C until
assayed. In nine patients, a sample of each exchange during a
single day was also obtained. All patients were routinely
evaluated every 3 months to assess hemodynamic and nutrition-
al status as well as biochemical control of uremia [121. In
addition, routine PDE bacterial cultures as well as cultures
obtained by a milipore filter technique [13] were performed
every 1 to 3 months on all patients as well as at the time of
clinical suspicion of peritonitis.
Peritonitis was suspected when cloudy fluid was observed by
the patient usually at the completion of a dialysis exchange. The
presence of fever, abdominal pain, and rebound tenderness
were considered supportive of the diagnosis. Elevated PDE
PMN counts (> 100 cells/mm3) and positive PDE cultures were
used to confirm the diagnosis of peritonitis. Episodes in patients
with all the above clinical manifestations and elevated PDE cell
counts, but in whom no organisms were isolated, were termed
culture-negative peritonitis. All episodes of peritonitis and
results of bacterial cultures were recorded during the study
interval.
Preparation and characteristics of phagocytic cells. Perito-
neal cells were isolated from peritoneal dialysis fluid from
uninfected patients as previously described [14]. Cells were
suspended in Hank's balanced salt solution containing 0.1%
gelatin (GHBSS), in a final concentration of 5 x 106 PMØ/ml.
Total and differential cell counts were performed on all sam-
ples. Only patients that yielded greater than 75% PMØ and less
than 5% neutrophils were used in the phagocytic assays. PMØ
were also stained for the presence of nonspecific esterase and
greater than 90% of cells identified as PMØ by Wrights stain,
stained nonspecific esterase positive [15]. PMN were isolated
from heparinized venous blood of healthy donors as previously
described [161.
Bacterial species and radiolabeling of bacteria. Clinical
isolates of S. epidermidis and Escherichia coli obtained from
CAPD patients with peritonitis were maintained in our labora-
tory for these studies. For each experiment, bacteria were
grown in 10 ml of Mueller-Hinton broth (Difco Laboratories,
Detroit, Michigan) containing 20 pCi [3H] adenine (ICN Corpo-
ration, Irving, California) in a 37°C shaking incubator for 18 hr,
washed three times with phosphate-buffered saline (PBS), pH
7.4, and resuspended in GHBSS at a concentration of 5 x 108
colony-forming units (cfu)/ml [14, 16].
Opsonization of bacteria. Serum from five healthy donors
was pooled and stored at —70°C. This pooled human serum was
used as a source of heat-stable and heat-labile opsonins. Imme-
diately prior to its use, serum was thawed and diluted to the
desired concentration in GHBSS. Samples of PDE from CAPD
patients were processed in an identical manner. Radiolabeled
bacteria were opsonized by the addition of 0.1 ml of a bacterial
suspension (5 x iO7 cfu) to 0.9 ml of serum or PDE and
incubated for 15 mm at 37°C [14, 16]. Heating of serum or PDE
at 56°C for 30 mm was used to deplete these samples of heat-
labile opsonins.
Measurement of opsonic activity, The uptake by phagocytic
cells (PMØ and PMN) of radiolabeled bacteria opsonized by
serum or PDE was determined using an assay that has been
described in detail [14, 16]. Bacteria were added to phagocytes
in a ratio of about 10:1. The percent uptake of the total bacterial
population added to PMØ or PMN after a 30-mm incubation
period was taken as a measure of the opsonic activity of a given
sample.
Determination of IgG and C3. The concentration of IgG and
C3 in serum and PDE samples were determined nephelometri-
cally (Hyland Diagnostics, Deerfield, Illinois) using nephelo-
metric grade antibodies (Atlantic Antibodies, Scarborough,
Maryland).
Statistical analysis. Where applicable data were expressed as
mean SE. Data were compared using the Student's t test.
Corrected x2 and Fisher's exact tests were used to evaluate
statistical significance between patient groups. A P value less
than 0.05 was considered significant. Coefficient of correlation
was determined by the least squares technique.
Results
Patient population. The mean age of the 17 CAPD patients
was 64.2 2.8 years; 13 were female and four were male.
Chronic renal failure was related to diabetes mellitus in three
patients (insulin-dependent [type 11 in one and noninsulin-
dependent [type 2] in two). No significant correlation could be
established between previous therapy or length of time on
CAPD before entry into study and incidence of peritonitis,
opsonic activity of PDE, or concentration of IgG in PDE.
Significant correlations between specific underlying disease and
opsonic activity could not be established although the three
patients with diabetes mellitus had high PDE opsonic activity.
No major differences were observed in the various biochemical
parameters monitored in any of the 17 patients.
Determination of PDE opsonic activity relative to serum. The
ability of PDE to opsonize S. epidermidis orE. coli and thereby
promote phagocytosis by either PMØ or PMN was first evaluat-
ed utilizing PDE that had been pooled from ten uninfected
patients obtained at the completion of overnight exchanges.
The opsonic activity for S. epidermidis present in pooled PDE
was approximately 1/50 to 1/100 of that observed in pooled
normal serum (Fig. 1). The opsonic activity of pooled PDE and
serum for S. epidermidis was heat-stable since heat inactivation
did not change this activity. In addition, PMØ phagocytized S.
epidermidis comparably to PMN. In contrast, phagocytosis of
E. co/i by PMØ or PMN required a heat-labile factor which was
present in serum but not in pooled PDE. Of note was that PMØ
were less efficient than PMN in their ability to phagocytize E.
co/i when this organism was opsonized with normal serum (Fig.
1).
Opsonic activity of individual patient PDE. Patients were
observed for 2 to 11 months; between one and four overnight
PDE samples from each patient were assayed for opsonic
activity for S. epidermidis. The opsonic activity for S. epidermi-
dis varied widely in the overnight PDE among individual
patients (Fig. 2) but remained relatively constant for each
patient during the study interval (< 10% difference in opsonic
activity of PDE samples from an individual patient). Samples of
PDE obtained from patient exchanges performed during the day
had 10 to 20% lower opsonic activity compared to the overnight
0
Fig. 2. Percent uptake of S. epidermidis or E. coli by human peritoneal
macrophages (PMØ) opsonized by undiluted overnight peritoneal dialy-
sis effluent (PDE). Each point in the left-hand panel represents the
mean value of opsonic activity against S. epidermidis in each of the 17
CAPD patients. Open circles represent patients with "high" opsonic
activity. Closed circles represent patients with "low" opsonic activity.
The mean value for each group is depicted by the bar. The mean
opsonic activity of PDE against E. coli in each patient is depicted in the
right-hand panel.
Episodes of peritonitis. The total clinical exposure for all
patients was 102 months. During this period ten episodes of
peritonitis occurred with an incidence of one episode per 10.2
patient months. S. epidermidis was isolated in seven episodes
and an unidentified gram-negative bacillus in one patient. In
two patients the clinical features of peritonitis were present,
associated with an increased PMN count in the PDE, but no
organisms were cultured by routine bacteriologic techniques or
by the milipore filter technique [13].
PDE opsonic activity and peritonitis. The ten episodes of
peritonitis were examined in relationship to the individual
patient PDE opsonic activity. Seven of the ten episodes of
peritonitis occurred in patients with PDE opsonic activity of
less than 30% phagocytosis. Based on this value, patients were
divided into two groups, those with opsonic activity of less than
30% phagocytosis (group 1) and those with opsonic activity of
greater than 30% phagocytosis (group 2). Seven of the patients
(4 1%) were in group 1; the mean opsonic activity in this group
was less than half of that in group 2 (Table 1). The frequency of
peritonitis was significantly higher in group 1 (P < 0.05). When
only peritonitis caused by S. epidermidis was considered (Table
1), group 1 patients had nearly a tenfold greater incidence of
peritonitis. There was one episode per 6.7 patient months in
group 1 while there was only one episode per 62 patient months
in group 2 (P < 0.05).
Correlation of opsonic activity and PDE concentration of IgG
and C3
Since IgG is a major heat-stable opsonin and C3 is an
important component of the heat-labile opsonic system, IgG
and C3 concentrations were determined in all PDE. Serum
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Fig. 1. Percent uptake of a strain of S.
epidermidis and E. coli opsonized in various
dilutions of either pooled normal serum or
pooled peritoneal dialysis effluent. Each data
point represents the mean and ranges of three
different determinations. Abbreviations are:
polymorphonuclear leukocytes, PMN;
peritoneal macrophages, PMØ.
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samples. A detectable increase in PDE opsonic activity against
S. epidermidis was not observed in patients studied 1 month
after an episode of peritonitis. Opsonic activity against E. coli
was not detected in any PDE from any patient evaluated (Fig.
2).
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Table 1. Peritonitis and opsonic activity of dialysate effluenta
Group 1 Group 2
Number of patients 7 10
Total months exposure 40 62
Mean opsonic activity 17.4 1.4% 45.9 2.4%
Episodes of peritonitis 7 3
Organisms
S. epidermidis
Gram-negative bacillus
Culture negative
6
0
1
1
I
1
Episodes of peritonitis per patient
month l/5.7b 1/24
Episodes of S. epidermidis peritonitis
per patient month l/6.7' 1/62
Groups I and 2 denote patients with "low"
activity against S. epidermidis, respectively.bP < 0.05 compared to group 2.
or "high" opsonic
concentrations of IgG and C3 in all 17 CAPD patients were
within normal ranges. In ten patients simultaneous determina-
tion of serum IgG and PDE IgG were performed. Serum IgG
was 1,064.5 100.4 mgldl and PDE IgG was 7.2 2.1 mg/dl.
Not only was there greater variability in PDE IgG than serum
levels, but the highest serum IgG concentrations were not
predictive of the highest PDE IgG. Since only samples from an
overnight exchange were studied, the dwell-time was similar (8
to 9 hr) for all patients.
Mean PDE IgG concentration in group 1 patients was 5.3
0.7 mg!dl compared to 16.6 2.1 mg/dl in group 2 patients (P <
0.05). The IgG concentration of individual PDE samples corre-
lated linearly with the PDE total protein concentration (r =
0.99; P < 0.05). Comparison between PDE IgG concentration
and PDE opsonic activity also revealed a significant correlation
(r = 0.93; P < 0.05). Although a low PDE IgG concentration
was always associated with a low opsonic activity, some PDE
samples with high IgG concentrations had opsonic activity that
was less than 30% phagocytosis. These data suggest that
although there is a relationship between the quantity of IgG and
opsonic activity for S. epidermidis, qualitative factors such as
antibody specificity may also be important. These results also
imply that some CAPD patients may have relatively lower
levels of this heat-stable opsonin despite normal serum levels of
IgG. Group 1 patient PDE C3 levels (1.65 0.2 mg!dl) were not
significantly different than those determined in group 2 patients
(1.75 0.3 mg/dl).
Discussion
Phagocytic cells play a fundamentally important role in the
defense of the human host against bacterial pathogens. The
contribution of opsonic molecules to host defenses against
infection has been demonstrated in a variety of diseases [9—11].
A quantitative deficiency of opsonins can seriously compromise
the bactericidal function of phagocytic cells [17, 18]. Although
normal serum has ample amounts of heat-stable and heat-labile
opsonins for most bacteria, the relative concentrations of these
factors at the site of bacterial invasion is probably most critical
in determining whether or not clinical infection develops. In this
regard, infection of the peritoneal cavity by gram-negative
organisms in patients with alcoholic cirrhosis and ascites, has
been suggested to be related to a deficiency of heat-labile
opsonins in ascitic fluid secondary to decreased C3 levels [18,
19]. In contrast nonascitic peritoneal fluid obtained from pa-
tients undergoing diagnostic laporotomy or laporoscopy con-
tains C3 levels and concentrations of IgG that are not markedly
different from normal serum [20, 21).
In the present study, S. epidermidis, when opsonized by
normal or heated serum, was readily phagocytized by PMØ,
the putative first line of phagocytic defense of the peritoneal
cavity. Similar results were also observed with PMN. Normal
serum could be diluted to 1% of its original concentration and
still promote phagocytosis of S. epidermidis. However, of
critical importance to the local defense of the peritoneal cavity
in CAPD patients is the extremely low levels of opsonins found
in PDE. The concentration of opsonic activity for S. epidermi-
dis in pooled PDE was only 1/50 to 1/100 of that observed in
pooled normal serum. The opsonic activity of PDE for S.
epidermidis, was predominantly heat-stable and appears related
to low levels of IgG in PDE. Considerable variation in PDE
opsonic activity among individual CAPD patients was found
(Fig. 2), and six of the seven episodes of S. epidermidis
peritonitis occurred in those patients in whom PDE opsonic
activity was "low" (17.4 1.4% phagocytosis). Only one
patient with "high" PDE opsonic activity (45.9 2.4% phago-
cytosis) developed S. epidermidis peritonitis. There was one
episode of culture negative peritonitis in each group. The single
episode of gram-negative peritonitis occurred in a patient with
"high" heat-stable opsonic activity. Although gram-negative
peritonitis occurs in CAPD patients, the predominance of S.
epidermidis peritonitis probably reflects the more common
exposure to this organism during the dialysis exchange
procedure.
Heat-labile opsonic activity for E. co/i was consistently
absent in all PDE, and this was associated with extremely low
levels of PDE C3. Moreover, E. coil even when opsonized with
normal human serum was less efficiently phagocytized by PMØ
than by PMN. It is possible that the heat-labile opsonic defi-
ciency of PDE coupled with the less efficient phagocytosis of
certain E. co/i by PMØ could explain, in part, the longer clinical
course of gram-negative compared to S. epidermidis peritonitis
that has been reported in CAPD patients [22].
Of interest in this study was the wide range in IgG concentra-
tions in PDE as well as variability in the specificity of the PDE
IgG to promote phagocytosis of S. epidermidis. The variability
in the IgG concentration did not appear to correlate with serum
levels of IgG nor length of dwell-time of dialysis solution. Since
nearly all patients utilized a 2.5% dialysate glucose concentra-
tion in the overnight exchange differences in IgG loss cannot be
explained by changes in convective transport of IgG induced by
osmotic load. It is of note that three of the patients with PDE
IgG concentrations greater than 10 mgldl had diabetes mellitus,
a disease associated with increased macromolecular permeabili-
ty in other vascular beds [23]. Hence, it is possible that
individual patient differences in the permeability of the perito-
neal membrane could have profound effects on the IgG that
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gains entrance to the peritoneal cavity. In addition, in uninfect-
ed patients 24-hr IgG loss in dialysate effluent varies fourfold
[241, and thus, it is not surprising that we find differences in the
concentration of IgG in the overnight exchange. The variability
in the op sonic activity of PDE IgG may be related to differences
in levels of specific IgG antibodies against S. epidermidis. Since
PDE opsonic activity is most likely a reflection of serum
antibody activity [25], differences in serum antibody levels
against S. epidermidis could become significant when 2 liters of
dialysis solution are instilled into the abdominal cavity.
The pathogenesis of peritonitis in CAPD patients is multifac-
tonal and includes technical as well as patient factors, such as
age, attention to techniques, and underlying disease. Our data
indicate that host defenses of the peritoneal cavity play an
important role in the development of peritonitis. Specifically,
defense of the peritoneal cavity against S. epidermidis depends
on the presence of adequate heat-stable opsonins. The frequen-
cy of potential exposure to S. epidermidis compared to E. coli
suggest that a deficiency in opsonic activity in PDE against S.
epidermidis has greater clinical importance.
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